Skip to main content

Life Sciences

By Anthony Vecchione | 06:29 pm | August 27, 2024
Waltz Health partners with Reliance Rx for specialty drug access, and Marshall Health Network and Primefocus Health collaborate on services for regional healthcare.
By Nathan Eddy | 02:31 pm | August 23, 2024
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
By Anthony Vecchione | 02:31 pm | August 22, 2024
The company will use the funds to expand partnerships with mental health nonprofits and government agencies.
By Jessica Hagen | 07:39 pm | August 19, 2024
The company will use the funds to grow its team, accelerate product development and test strategies to scale its business.
By Jessica Hagen | 03:13 pm | August 19, 2024
The solicitation seeks projects that leverage technology and the microgravity environment in space to create therapies to treat significant diseases on Earth.
By Jessica Hagen | 11:59 am | August 13, 2024
Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharma's perspective on digital health investments and partnerships for sector growth.
By Jessica Hagen | 06:30 pm | August 12, 2024
Create Health Ventures will focus on funding early-stage digital health companies led by founders with healthcare backgrounds.
By Jessica Hagen | 04:02 pm | July 29, 2024
ReviR Therapeutics secures $30 million for its drug discovery platform. RetiSpec raises $10 million for its eye-diagnostics offering. SoundHealth scores $7 million for its acoustics medical device for nasal congestion.
By HIMSS TV | 07:00 am | July 29, 2024
Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.
By Jessica Hagen | 01:30 pm | July 26, 2024
Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.